Details of the Drug
General Information of Drug (ID: DMP7MRC)
| Drug Name |
Bulleyaconitine A
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | XEL-002BP; Bulleyaconitine A (transdermal matrix patch/sustained release, pain); Bulleyaconitine A (transdermal matrix patch/sustained release, pain), Xel Pharmaceuticals | ||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||

